Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.36% | -43.27% | -45.62% | -23.23% | -10.55% |
| Total Depreciation and Amortization | -23.09% | -28.35% | 15.45% | 21.57% | 23.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.74% | 26.89% | 57.87% | 64.23% | 14.92% |
| Change in Net Operating Assets | -2,775.54% | 371.46% | 6,473.73% | -120.66% | -96.39% |
| Cash from Operations | -23.26% | -31.89% | -31.51% | -21.30% | -20.23% |
| Capital Expenditure | 98.73% | 84.99% | 8.50% | -98.12% | -106.74% |
| Sale of Property, Plant, and Equipment | -40.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.94% | 89.65% | 16.26% | -89.10% | -99.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -27.84% | -26.64% | -86.31% | -98.88% | -53.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -28.55% | -26.17% | -86.22% | -98.86% | -52.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.61% | -266.06% | -648.46% | -537.77% | -131.35% |